Languages

SEB Menu

As Canada’s leading arthritis patient voice, Arthritis Consumer Experts (ACE) has created a reader-friendly information hub for consumers to get the latest biosimilars news and background analysis through the Biosim•Exchange.

The Biosim•Exchange provides research-based information on biosimilar safety and effectiveness to inform consumers and patients and report on public and private health insurance formulary policy or listing decisions.

Our aim with the development and timely delivery of biosimilars information is to help patients better understand what they are and learn about their place among other inflammatory arthritis treatments. Armed with this knowledge, patients and their physicians can build stronger partnerships leading to improved shared decision-making and treatment plan results.